INCIDENCE OF ACUTE NONLYMPHOCYTIC LEUKEMIA, PRELEUKEMIA, AND ACUTE MYELOPROLIFERATIVE SYNDROME UP TO 10 YEARS AFTER TREATMENT OF HODGKIN'S DISEASEPEDERSEN BJERGAARD J; LARSEN SO.1982; N. ENGL. J. MED.; ISSN 0028-4793; USA; DA. 1982; VOL. 307; NO 16; PP. 965-971; BIBL. 38 REF.Article

Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase IIPEDERSEN-BJERGAARD, J.Leukemia research. 1992, Vol 16, Num 8, pp 733-735, issn 0145-2126Article

Incidence, previous treatment and chromosome characteristics of secondary acute non-lymphocytic leukemiaPEDERSEN-BJERGAARD, J.Cancer treatment reviews. 1985, Vol 12, Num 1, pp 65-75, issn 0305-7372Article

SEVERE APLASTIC ANAEMIA WITH COMPLETE AUTOLOGOUS MARROW RECONSTITUTION FOLLOWING TREATMENT WITH ANTITHYMOCYTE GLOBULIN: REPORT OF A CASE AND REVIEW OF THE LITERATUREPEDERSEN BJERGAARD J; ERNST P; NISSEN NI et al.1978; SCAND. J. HAEMATOL.; DNK; DA. 1978; VOL. 21; NO 1; PP. 14-18; BIBL. 22 REF.Article

Acute promyelocytic leukemia with t(15;17) following inhibition of DNA topoisomerase IIPEDERSEN-BJERGAARD, J.Annals of oncology. 1995, Vol 6, Num 8, pp 751-753, issn 0923-7534Article

Hodgkin's disease: recent concepts in classification and treatmentSPECHT, L; PEDERSEN-BJERGAARD, J.European journal of haematology. Supplementum. 1989, Vol 42, Num 48, pp 7-14, issn 0902-4506Article

Cytogenetic, clinical, and cytologic characteristics of radiotherapy-related leukemiasPHILIP, P; PEDERSEN-BJERGAARD, J.Cancer genetics and cytogenetics. 1988, Vol 31, Num 2, pp 227-236, issn 0165-4608Article

Therapy-related malignancies: a reviewPEDERSEN-BJERGAARD, J; PHILIP, P.European journal of haematology. Supplementum. 1989, Vol 42, Num 48, pp 39-47, issn 0902-4506Article

Chromosome characteristics of therapy-related acute non-lymphocytic leukemia and preleukemia: possible implications for pathogenesis of the diseasePEDERSEN-BJERGAARD, J; PHILIP, P.Leukemia research. 1987, Vol 11, Num 4, pp 315-318, issn 0145-2126Article

Two different classes of therapy-related and de-novo acute myeloid leukemia ?PEDERSEN-BJERGAARD, J; PHILIP, P.Cancer genetics and cytogenetics. 1991, Vol 55, Num 1, pp 119-124, issn 0165-4608Article

CLINICAL TRIAL OF PREDNIMUSTINE, LEO-1031 (NSC-134087), IN PATIENTS WITH NON-HODGKIN LYMPHOMATA AND CHRONIC LYMPHOCYTIC LEUKAEMIA PREVIOUSLY TREATED WITH STEROIDS AND ALKYLATING AGENTSPEDERSEN BJERGAARD J; HANSEN MM; GEISLER CH et al.1980; ACTA MED. SCAND.; SWE; DA. 1980; VOL. 207; NO 3; PP. 215-220; BIBL. 18 REF.Article

The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformationPEDERSEN-BJERGAARD, J; ROWLEY, J. D.Blood. 1994, Vol 83, Num 10, pp 2780-2786, issn 0006-4971Article

CLINICAL TRIAL OF RUBIDAZONE IN SOLID TUMORS AND MALIGNANT LYMPHOMAS.SKOVSGAARD T; HANSEN HH; MOURIDSEN HT et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 7; PP. 1053-1058; BIBL. 23 REF.Article

Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia : Rare events related to DNA-topoisomerase II inhibitors?DISSING, M; LE BEAU, M. M; PEDERSEN-BJERGAARD, J et al.Journal of clinical oncology. 1998, Vol 16, Num 5, pp 1890-1896, issn 0732-183XArticle

Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapyCHRISTIANSEN, D. H; PEDERSEN-BJERGAARD, J.Leukemia. 2001, Vol 15, Num 12, pp 1848-1851, issn 0887-6924Conference Paper

Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromereANDERSEN, M. K; PEDERSEN-BJERGAARD, J.Leukemia. 2000, Vol 14, Num 1, pp 105-111, issn 0887-6924Article

ABOLISHED PRODUCTION OF INTERFERON BY LEUCOCYTES OF PATIENTS WITH THE ACQUIRED CYTOGENETIC ABNORMALITIES 5Q- OR -5 IN SECONDARY AND DE-NOVO ACUTE NON-LYMPHOCYTIC LEUKAEMIAPEDERSEN BJERGAARD J; HAAHR S; PHILIP P et al.1980; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1980; VOL. 46; NO 2; PP. 211-223; BIBL. 2 P.Article

CHRONIC LYMPHOCYTIC LEUKAEMIA WITH SUBSEQUENT DEVELOPMENT OF MULTIPLE MYELOMA.PEDERSEN BJERGAARD J; PETERSEN HD; THOMSEN M et al.1978; SCAND. J. HAEMATOL.; DNK; DA. 1978; VOL. 21; NO 3; PP. 256-264; BIBL. 2 P.Article

Translocations and deletions with breakpoint on 21q are nonrandomly associated with treatment-related acute nonlymphocytic leukemia and preleukemiaKELDSEN, N; PHILIP, P; PEDERSEN-BJERGAARD, J et al.Cancer genetics and cytogenetics. 1987, Vol 29, Num 1, pp 43-55, issn 0165-4608Article

Possible pathogenetic significance of specific chromosome abnormalities and activated proto-oncogenes in malignant diseases of manPEDERSEN-BJERGAARD, J; ANDERSSON, P; PHILIP, P et al.Scandinavian journal of haematology. 1986, Vol 36, Num 2, pp 127-137, issn 0036-553XArticle

High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedurePEDERSEN-BJERGAARD, J; PEDERSEN, M; MYHRE, J et al.Leukemia. 1997, Vol 11, Num 10, pp 1654-1660, issn 0887-6924Article

Methylation of p15^INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemiaCHRISTIANSEN, D. H; ANDERSEN, M. K; PEDERSEN-BJERGAARD, J et al.Leukemia. 2003, Vol 17, Num 9, pp 1813-1819, issn 0887-6924, 7 p.Article

Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AMLANDERSEN, M. K; CHRISTIANSEN, D. H; PEDERSEN-BJERGAARD, J et al.Leukemia. 2005, Vol 19, Num 2, pp 197-200, issn 0887-6924, 4 p.Article

Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progressionERSBOLL, J; SCHULTZ, H. B; PEDERSEN-BJERGAARD, J et al.European journal of haematology. 1989, Vol 42, Num 2, pp 155-163, issn 0902-4441Article

RADIOTHERAPY VERSUS RADIOTHERAPY PLUS CHEMOTHERAPY IN STAGES 1 AND II HODGKIN'S DISEASE. A PROSPECTIVE, RANDOMIZED STUDY BY THE DANISH NATIONAL HODGKIN STUDY GROUP. LYGRANISSEN NJ; NORDENTOFT AM; BRINCKER H et al.1980; SCAND. J. HAEMATOL.; ISSN 0036-553X; DNK; DA. 1980; VOL. 25; NO 1; PP. 35-44; BIBL. 16 REF.Article